Skip to content
GILEAD SCIENCES, INC. (GILD) Stock Price & Insider Trading
Home / Companies / GILD GIL
GILEAD SCIENCES, INC. (GILD) S&P 500 NASDAQ-100 XNAS BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Net insider selling (90d)
Latest GILD Insider Trades
About GILEAD SCIENCES, INC. (GILD) Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
Headquarters FOSTER CITY, CA
Employees 17,000
Listed 1992
Exchange XNAS https://www.gilead.com SEC filings for GILD on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 26 111,000 $15.02M Option exercise 27 138,990 Tax withholding / forfeiture 6 10,349
GILD Insider Transactions (Form 4) 88 102 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 3 of 3.
Date Insider Transaction Security Shares Price Value Nov 17, 2025 JM Johanna Mercier - Officer Option exercise Common Stock 25,000
Recent GILD Form 8-K Filings 5
Recent GILD Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 26, 2026 ANTHONY WELTERS Director 18,000 $2.68M View on EDGAR Aug 20, 2026 JEFFREY BLUESTONE Director
GILD Insider Trading - FAQ
What is the latest insider trade for GILD? GILEAD SCIENCES, INC. (GILD) had 17 insider filings in the last 90 days, with the most recent on 2026-08-27. The full record for GILD runs to 102 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying GILD stock? No insider purchases of GILD were filed in the last 90 days.
How many insiders are selling GILD stock? 26 insider sales of GILD were filed in the last 90 days, totaling $15.02M.
Where can I see GILD SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks GILD Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow GILD insider buys? Create a free InsiderAlpha account and press Watch on this page to add GILD to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track GILD insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free $685K
Market cap $180.64B
P/E ratio -
Dividend yield 2.27%
Average volume 7.57M
52 week high $157.29
52 week low $108.46
Today's high $149.47
Today's low $144.88
Open $149.47
Volume 3.95M
Previous close $148.86
Shares outstanding 1.24B Market cap
$180.64B
17,000 employees
GILD Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 26 sales totaling $15.02M.
Most-Active GILD Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Nov 17, 2025 JM Johanna Mercier - Officer Open-market sale Common Stock 25,524 $125.83 $3.21M
Nov 17, 2025 JM Johanna Mercier - Officer Open-market sale Common Stock 2,476 $126.26 $313K
Nov 17, 2025 JM Johanna Mercier - Officer Option exercise Non-qualified Stock Option (Right to Buy) 25,000 $0.00 -
Nov 12, 2025 DT Deborah H. Telman - Officer Open-market sale Common Stock 17,181 $124.00 $2.13M
Nov 12, 2025 DT Deborah H. Telman - Officer Option exercise Common Stock 35,965 $60.75 $2.18M
Nov 12, 2025 DT Deborah H. Telman - Officer Open-market sale Common Stock 35,965 $122.30 $4.40M
Nov 12, 2025 DT Deborah H. Telman - Officer Option exercise Non-qualified Stock Option (Right to Buy) 17,181 $0.00 -
Nov 12, 2025 DT Deborah H. Telman - Officer Option exercise Non-qualified Stock Option (Right to Buy) 35,965 $0.00 -
Nov 12, 2025 DT Deborah H. Telman - Officer Option exercise Non-qualified Stock Option (Right to Buy) 500 $0.00 -
Nov 12, 2025 DT Deborah H. Telman - Officer Option exercise Common Stock 17,181 $75.12 $1.29M
Oct 25, 2025 DT Deborah H. Telman - Officer Tax withholding / forfeiture Common Stock 241 $120.94 $29K
Oct 15, 2025 JM Johanna Mercier - Officer Open-market sale Common Stock 3,000 $118.08 $354K
Sep 22, 2025 EB Erin Burkhart - Officer Grant or award Restricted Stock Unit 8,890 - -
Sep 15, 2025 JM Johanna Mercier - Officer Open-market sale Common Stock 3,000 $113.57 $341K
Sep 10, 2025 DT Deborah H. Telman - Officer Tax withholding / forfeiture Common Stock 634 $115.25 $73K
Sep 10, 2025 JM Johanna Mercier - Officer Tax withholding / forfeiture Common Stock 1,819 $115.25 $210K
Sep 10, 2025 JM Johanna Mercier - Officer Option exercise Restricted Stock Unit 3,844 - -
Sep 10, 2025 DO Daniel Patrick O'Day - Officer Tax withholding / forfeiture Common Stock 4,949 $115.25 $570K
Sep 10, 2025 DW Diane E. Wilfong - Officer Tax withholding / forfeiture Common Stock 338 $115.25 $39K
Sep 10, 2025 DW Diane E. Wilfong - Officer Option exercise Restricted Stock Unit 921 - -
Sep 10, 2025 AD Andrew D. Dickinson - Officer Tax withholding / forfeiture Common Stock 1,751 $115.25 $202K
Aug 15, 2025 JM Johanna Mercier - Officer Option exercise Common Stock 11,800 $66.64 $786K
Aug 15, 2025 JM Johanna Mercier - Officer Open-market sale Common Stock 11,800 $118.50 $1.40M
Aug 15, 2025 JM Johanna Mercier - Officer Option exercise Common Stock 700 $66.64 $47K
Aug 15, 2025 JM Johanna Mercier - Officer Open-market sale Common Stock 700 $118.97 $83K
Aug 15, 2025 JM Johanna Mercier - Officer Option exercise Common Stock 11,800 $66.64 $786K
Aug 15, 2025 JM Johanna Mercier - Officer Open-market sale Common Stock 11,800 $118.51 $1.40M
Aug 15, 2025 JM Johanna Mercier - Officer Option exercise Common Stock 700 $66.64 $47K
Aug 15, 2025 JM Johanna Mercier - Officer Open-market sale Common Stock 700 $118.97 $83K
Aug 15, 2025 JM Johanna Mercier - Officer Open-market sale Common Stock 2,800 $118.51 $332K
Aug 15, 2025 JM Johanna Mercier - Officer Open-market sale Common Stock 200 $118.97 $24K
Aug 15, 2025 JM Johanna Mercier - Officer Option exercise Non-qualified Stock Option (Right to Buy) 11,800 $0.00 -
Aug 15, 2025 JM Johanna Mercier - Officer Option exercise Non-qualified Stock Option (Right to Buy) 700 $0.00 -
Aug 15, 2025 JM Johanna Mercier - Officer Option exercise Non-qualified Stock Option (Right to Buy) 11,800 $0.00 -
Aug 15, 2025 JM Johanna Mercier - Officer Option exercise Non-qualified Stock Option (Right to Buy) 700 $0.00 -
Jul 25, 2025 DT Deborah H. Telman - Officer Tax withholding / forfeiture Common Stock 3,823 $116.20 $444K
Jul 15, 2025 JM Johanna Mercier - Officer Open-market sale Common Stock 3,000 $111.03 $333K
Jul 14, 2025 JB Jeffrey Bluestone - Director Option exercise Common Stock 5,000 $67.45 $337K
Jul 14, 2025 JB Jeffrey Bluestone - Director Open-market sale Common Stock 5,000 $109.74 $549K
Jul 14, 2025 JB Jeffrey Bluestone - Director Option exercise Non-qualified Stock Option (Right to Buy) 5,000 $0.00 -
May 7, 2025 AW Anthony Welters - Director Grant or award Common Stock 1,516 $0.00 -
May 7, 2025 AW Anthony Welters - Director Grant or award Non-qualified Stock Option (Right to Buy) 6,809 $0.00 -
May 7, 2025 JB Jacqueline K. Barton - Director Grant or award Non-qualified Stock Option (Right to Buy) 6,809 $0.00 -
May 7, 2025 TL Ted W. Love - Director Grant or award Common Stock 1,516 $0.00 -
May 7, 2025 TL Ted W. Love - Director Grant or award Non-qualified Stock Option (Right to Buy) 6,809 $0.00 -
Dec 13, 2023 SP Sandra Patterson - Officer Tax withholding / forfeiture Common Stock 298 $83.09 $25K
Dec 13, 2024 SP Sandra Patterson - Officer Tax withholding / forfeiture Common Stock 157 $91.86 $14K
Dec 13, 2023 SP Sandra Patterson - Officer Option exercise Restricted Stock Unit 181 - -
Dec 13, 2023 SP Sandra Patterson - Officer Option exercise Restricted Stock Unit 117 - -
Dec 13, 2024 SP Sandra Patterson - Officer Option exercise Restricted Stock Unit 157 - -
Dec 10, 2024 MP Merdad Parsey - Officer Option exercise Common Stock 3,820 - -
Dec 10, 2024 MP Merdad Parsey - Officer Tax withholding / forfeiture Common Stock 1,771 $92.34 $164K
Dec 10, 2024 MP Merdad Parsey - Officer Option exercise Restricted Stock Unit 3,820 - -
$GPCR
Structure Therapeutics Inc.
